Infectious Disease and Vaccine Clinical Research Studies

Supporting Antiviral, Antibacterial, Antifungal and Vaccine Clinical Research

Achieve quality results, meet deadlines, and maximize efficiencies by partnering with a full-service CRO that excels in designing and executing clinical research in antivirals, antibacterials, antifungals and vaccines. As a global CRO with a therapeutic focus on infectious diseases and vaccines, we:

Creatively approach novel compounds and delivery mechanisms
Quickly mobilize and enroll for acute diseases and during peak seasons
Anticipate challenges and proactively navigate rapidly evolving regulations, operational complexities and tight timelines

Infectious Diseases and Vaccines Experience

Extensive experience gives our medical, regulatory, and operational staff a thorough understanding of the complexities of ID trials from the perspectives of all the stakeholders involved in developing treatments for new and re-emerging infectious diseases:

Broad experience designing and conducting global Phase I-IV clinical trials in antivirals, antibacterials, antifungals and vaccines
Spans adult and pediatric populations
Assist sponsors with securing government and non-dilutive funding such as BARDA, NIH, and Wellcome-Trust

Central Laboratory and Specialty Lab Support

Medpace provides central laboratory services to support global trials and coordinates the often complex logistics with global specialty testing labs. We work collaboratively with top labs in microbiology and virology to provide the specific testing required for each study. This approach streamlines timelines, simplifies requirements for sites, and provides a centralized model for communication.

Medpace’s lab relationships plus central lab model gives sponsors a competitive advantage:

Access to top research scientists who are therapeutically focused in infectious disease, deliver regulatory-quality reports and meet the tight timelines demanded in ID trials
With Medpace central labs coordinating the shipping between sites and labs around the world, logistics are greatly simplified, resulting in higher efficiency
Specialty labs integrate seamlessly with Medpace’s full-service approach to clinical trial management

The Medpace Difference for Infectious Diseases and Vaccines Studies

Infectious disease and vaccine clients benefit from partnering with Medpace in numerous ways:

Board-certified infectious disease physicians with backgrounds in academic hospitals, pharmaceutical companies and public health organizations. As published thought leaders, they regularly review articles for scientific journals, speak at industry events and consult with academic institutions and pharmaceutical companies
Insight into evolving regulations through our ongoing interactions with FDA’s anti-infective division and participation in sponsor meetings with regulatory agencies
Collaborative work and insights from strategic specialty labs, recognized as some of the top leaders in microbiology, virology, and PK-PD modeling